Your browser doesn't support javascript.
loading
Corrigendum to "Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer" [Translational Oncology (2019) 12, 764-774].
Zhou, Dabo; Liu, Liping; Liu, Jingyu; Tang, Yu; Xiao, Mengjia; Wang, Yikai; He, Qiongzhi; Hu, Zhe-Yu; Ouyang, Quchang.
Afiliación
  • Zhou D; Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Ho
  • Liu L; Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Ho
  • Liu J; Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Ho
  • Tang Y; Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Ho
  • Xiao M; Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Ho
  • Wang Y; Department of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Atlanta, 33022, USA.
  • He Q; Geneplus Beijing Institute, Beijing 102206, China.
  • Hu ZY; Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Ho
  • Ouyang Q; Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, Hunan, Cancer Hospital, Changsha, 410013, China; Department of Breast Cancer Medical Oncology, the Affiliated Cancer Ho
Transl Oncol ; 14(12): 101226, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34614466
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Oncol Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos